Search
First Alzheimer’s drug to slow disease progression gets full FDA approval
- Care For A Cure
- Jul 9, 2023
- 1 min read
The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.

Comments